Clinical Trials in North Carolina

Showing 11521-11540 of 17,036 trials

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

NCT00430638

This 16 week study will examine the ability of olmesartan medoxomil to lower the blood pressure of patients with moderate to severe high blood pressure in comparison to placebo. The medication being tested has been approved by the FDA for the treatment of high blood pressure.

Hypertension

Daiichi Sankyo278 participantsStarted Dec 2006

Birmingham, Alabama, United States • Mobile, Alabama, United States • Muscle Shoals, Alabama, United States +26 more locations

COMPLETEDNA46 miles

Evaluation of Regional Lung Deposition of Inhaled Saline Using the tPAD Device

NCT03185650

Purpose: Characterize the depositional attributes of a specialized trans-nasal aerosol delivery device in healthy people using clinical measurements of mucociliary clearance. Procedures (methods): 14% hypertonic saline (HS) aerosol containing the radio tracer Tc99m-sulfur colloid will be delivered via the tPAD and compared to the well characterized PARI LC Star nebulizer (7% HS) using planar gamma scintigraphy (i.e. particle clearance). The fraction of sulfur colloid particles that clear over the ensuing 24 hours with each device will indicate the fraction deposited in conducting airways.

Lung Diseases

University of North Carolina, Chapel Hill12 participantsStarted Jul 2017

Chapel Hill, North Carolina, United States

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

Evaluation of Regional Lung Deposition of Inhaled Saline Using the tPAD Device

Find Trials by Condition in North Carolina

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus

Multicenter Continuous Peripheral Nerve Block Surveillance Study

Phase II Combination Steroid and Anti-VEGF for Persistent DME

A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Medical Therapy of Prostatic Symptoms

Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial

Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors

Assessing Fitting Guides in Alcon Multifocal Contact Lenses

Gastric Electrical Stimulation (GES) for the Treatment of Obesity

PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris